Kent Lake PR LLC, a holder of approximately 6.9% of Quanterix Corporation's common stock, issued a statement on May 23, 2025, responding to Akoya Biosciences' disclosure of an unsolicited all-cash offer at $1.40 per share. Kent Lake noted this offer represented a 22% premium over Akoya's 30-day VWAP and Quanterix's implied offer price under the amended merger agreement.
Kent Lake urged the Quanterix Board not to increase its cash consideration for Akoya, stating that doing so would place Quanterix's balance sheet at significant risk and represent a breach of fiduciary duty. The shareholder highlighted that Quanterix trades at a material discount to its net cash position, reflecting investor concerns over value destruction from the Akoya transaction.
The firm called upon the Quanterix Board to allow Akoya to accept the clearly superior proposal without increasing Quanterix's purchase consideration. This response underscores the intense pressure on Quanterix regarding the merger and the potential for Akoya shareholders to realize a higher value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.